<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(2)</volume><submitter>Zheng M</submitter><pubmed_abstract>&lt;b>Background/Objectives:&lt;/b> This study aimed to construct a risk score (RS) based on necroptosis-associated genes to predict the prognosis of patients with advanced epithelial ovarian cancer (EOC). &lt;b>Methods:&lt;/b> EOC data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) series 140082 (GSE140082) were used. Based on known necroptosis-associated genes, clustering was performed to identify molecular subtypes of EOC. A least absolute shrinkage and selection operator (LASSO)-Cox regression analysis identified key genes related to prognosis. The expression of one of them, &lt;i>RIPK3&lt;/i>, was analyzed via immunohistochemistry in an EOC cohort. &lt;b>Results:&lt;/b> An RS made from ten genes (&lt;i>IDH2&lt;/i>, &lt;i>RIPK3&lt;/i>, &lt;i>FASLG&lt;/i>, &lt;i>BRAF&lt;/i>, &lt;i>ITPK1&lt;/i>, &lt;i>TNFSF10&lt;/i>, &lt;i</pubmed_abstract><journal>Cancers</journal><pagination>271</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11763378</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer.</pubmed_title><pmcid>PMC11763378</pmcid><pubmed_authors>Schroeder L</pubmed_authors><pubmed_authors>Kessler M</pubmed_authors><pubmed_authors>Keckstein S</pubmed_authors><pubmed_authors>Czogalla B</pubmed_authors><pubmed_authors>Zheng M</pubmed_authors><pubmed_authors>Reichenbach J</pubmed_authors><pubmed_authors>Mahner S</pubmed_authors><pubmed_authors>Kaltofen T</pubmed_authors><pubmed_authors>Jeschke U</pubmed_authors><pubmed_authors>Burges A</pubmed_authors><pubmed_authors>Trillsch F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer.</name><description>&lt;b>Background/Objectives:&lt;/b> This study aimed to construct a risk score (RS) based on necroptosis-associated genes to predict the prognosis of patients with advanced epithelial ovarian cancer (EOC). &lt;b>Methods:&lt;/b> EOC data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) series 140082 (GSE140082) were used. Based on known necroptosis-associated genes, clustering was performed to identify molecular subtypes of EOC. A least absolute shrinkage and selection operator (LASSO)-Cox regression analysis identified key genes related to prognosis. The expression of one of them, &lt;i>RIPK3&lt;/i>, was analyzed via immunohistochemistry in an EOC cohort. &lt;b>Results:&lt;/b> An RS made from ten genes (&lt;i>IDH2&lt;/i>, &lt;i>RIPK3&lt;/i>, &lt;i>FASLG&lt;/i>, &lt;i>BRAF&lt;/i>, &lt;i>ITPK1&lt;/i>, &lt;i>TNFSF10&lt;/i>, &lt;i</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-04-18T03:12:16.429Z</modification><creation>2025-04-03T23:22:44.987Z</creation></dates><accession>S-EPMC11763378</accession><cross_references><pubmed>39858052</pubmed><doi>10.3390/cancers17020271</doi></cross_references></HashMap>